Close Menu

NEW YORK – Quidel announced Friday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for the intended use of serial SARS-CoV-2 screening using its Sofia SARS Antigen FIA test.

The Sofia SARS Antigen FIA test is now available without a prescription and can be used in CLIA-waived settings.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.